19 августа, 2024

Influence of Socioeconomic Factors on Liver Transplant Survival Outcomes in Patients with Autoimmune Liver Disease in the United States

Introduction Autoimmune liver diseases (AILDs) such as autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC) are chronic inflammatory disorders affecting the hepatobiliary system. These diseases account for a small percentage of liver transplants (LT) in the United States, with survival outcomes influenced by various factors including disease burden, medical comorbidities, and […]

17 августа, 2024

Hepatitis C Virus NS5A and Core Protein Induce Fibrosis-Related Gene Regulation in Huh7 Cells Through Activation of LX2 Cells

Introduction Hepatocellular carcinoma (HCC) is the primary form of liver cancer and the second leading cause of cancer-related deaths globally, with approximately 140,000 cases attributed to chronic hepatitis C virus (HCV) infection. HCV is a hepatotropic positive-sense RNA virus that encodes a polyprotein, generating various structural and non-structural proteins. Chronic liver damage leads to unregulated […]

15 августа, 2024

Interplay Between Drug-Induced Liver Injury and Gut Microbiota: A Comprehensive Overview

Introduction Recent research has revealed a close association between drug-induced liver injury (DILI) and gut microbiota. However, the specific mechanisms of gut microbiota involvement in DILI remain unclear. This review examines how gut microbiota interacts with common hepatotoxic drugs and its potential role in DILI pathogenesis, offering a comprehensive reference for the interplay between DILI […]

1 августа, 2024

Top 5 Shocking Facts About Fatty Liver Disease: A Dietitian’s Perspective

Introduction Fatty liver disease, also known as non-alcoholic fatty liver disease (NAFLD), is becoming one of the most serious threats to modern healthcare. In recent years, we have observed an alarming increase in cases of fatty liver disease, affecting not only adults but also children. First described as a medical concept in the mid-20th century, […]

10 июля, 2024

Hepatitis Under Control: How New Methods Are Saving Lives

Introduction Hepatitis remains one of the major global medical challenges. As of 2023, over 296 million people worldwide live with chronic hepatitis B, and 58 million suffer from chronic hepatitis C. These diseases pose a serious threat to health, causing a wide range of complications, from liver cirrhosis to liver cancer. Hepatitis B: The Scope […]

5 июня, 2024

Study Global Burden of Disease: a germ, but more than 1 million deaths

Erkenntnis 5 bacterial pathogens – Staphylococcus aureus, Escherichia coli, Streptococcus pneumoniae, Klebsiella pneumoniae and Pseudomonas aeruginosa – were collectively responsible for over 50 % of global bacterial deaths in 2019. Why this matters Prevention measures and, especially in very young patients, visits to the doctor should be called upon if infections are suspected. Key results 33 investigated bacterial pathogens were in […]

23 мая, 2024

Some patients with neuroendocrine tumors prefer quality of life over longevity

Patients with neuroendocrine tumors, who may have a much longer life expectancy than those with aggressive tumors, report prioritizing quality of life (QoL) factors, such as remaining independent, rather than longer survival. However, they believe that doctors often do not share their priorities, according to a study published in Journal of the National Comprehensive Cancer […]

10 мая, 2024

Hepcludex or Myrcludex B for hepatitis B with Delta agent?

Hepatitis B with Delta agent, also known as “superinfection,” is a serious viral disease that affects the liver. It is distinguished by a more rapid and severe course than hepatitis B virus. Patients infected with this virus are at risk of developing cirrhosis and liver cancer.According to official statistics, approximately 20 million individuals worldwide are […]

7 мая, 2024

Some noncardiac biomarkers are predictive of myocarditis from immune checkpoint inhibitors

Elevated levels of these noncardiac immune biomarkers should suggest the need to investigate the presence of myocarditis in cancer patients treated with immune checkpoint inhibitors. Researchers devised a new biomarker strategy to identify patients treated with immune checkpoint inhibitors (ICIs) who may develop myocarditis.Some biomarkers were raised up to 30 days before admission for myocarditis and […]

5 мая, 2024

Breakthrough in Liver Cirrhosis Treatment: OFO7788 in University Research

Introduction Liver cirrhosis is a complex and potentially fatal disease resulting from chronic inflammatory processes. This condition is characterized by the replacement of healthy liver cells with fibrous scar tissue, rendering the organ unable to perform its essential functions. According to the World Health Organization, liver cirrhosis claims the lives of 40 million people worldwide […]